Which of the following is approved for the treatment of cystic fibrosis with G551D mutation?
Biostrophin is a vehicle for gene therapy in Duchenne and Becker's muscular dystrophyPeginesatide is an erythropoietin analog for anemia of chronic kidney diseaseLumacaftor is a CFTR potentiator for cystic fibrosis with F508 mutationIvacaftor is a CFTR potentiator for cystic fibrosis with G551D mutation
Biostrophin
Peginesatide
Lumacaftor
Ivacaftor
All India exam